Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-136933
Filing Date
2017-04-25
Accepted
2017-04-25 17:04:03
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d291766d10ka.htm 10-K/A 230107
2 EX-31.3 d291766dex313.htm EX-31.3 3069
3 EX-31.4 d291766dex314.htm EX-31.4 3092
  Complete submission text file 0001193125-17-136933.txt   237282
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36620 | Film No.: 17781774
SIC: 2834 Pharmaceutical Preparations